Search

By integrating energy-efficient AIoT-based biosensor networks, healthcare systems can now predict COVID-19 outbreaks with unprecedented accuracy and speed, revolutionizing early detection and intervention strategies. Therefore, this paper explores the rapid growth of electronic technology in today's environment, driven by the proliferation of advanced devices capable of monitoring and controlling various healthcare systems. However, these devices' limited resources necessitate optimizing their utilization. To tackle this concern, we propose an enhanced Artificial Intelligence of Things (AIoT) system that utilizes the networking capabilities of IoT biosensors to forecast potential COVID-19 outbreaks. The system aims to efficiently collect data from deployed sensor nodes, enabling accurate predictions of possible disease outbreaks. By collecting and pre-processing diverse parameters from IoT nodes, such as body temperature (measured non-invasively using the open-source thermal camera TermoDeep), population density, age (captured via smartwatches), and blood glucose (collected via the CGM system), we enable the AI system to make accurate predictions. The model's efficacy was evaluated through performance metrics like the confusion matrix, F1 score, precision, and recall, demonstrating the optimal potential of the IoT-based wireless sensor network for predicting COVID-19 outbreaks in healthcare systems. [ABSTRACT FROM AUTHOR]

Tuberculosis (TB) is one of the leading infectious causes of death worldwide. The effective management and public health control of this disease depends on early detection and careful treatment monitoring. For many years, the microscopy-based analysis of sputum smears has been the most common method to detect and quantify Mycobacterium tuberculosis (Mtb) bacteria. Nonetheless, this form of analysis is a challenging procedure since sputum examination can only be reliably performed by trained personnel with rigorous quality control systems in place. Additionally, it is affected by subjective judgement. Furthermore, although fluorescence-based sample staining methods have made the procedure easier in recent years, the microscopic examination of sputum is a time-consuming operation. Over the past two decades, attempts have been made to automate this practice. Most approaches have focused on establishing an automated method of diagnosis, while others have centred on measuring the bacterial load or detecting and localising Mtb cells for further research on the phenotypic characteristics of their morphology. The literature has incorporated machine learning (ML) and computer vision approaches as part of the methodology to achieve these goals. In this review, we first gathered publicly available TB sputum smear microscopy image sets and analysed the disparities in these datasets. Thereafter, we analysed the most common evaluation metrics used to assess the efficacy of each method in its particular field. Finally, we generated comprehensive summaries of prior work on ML and deep learning (DL) methods for automated TB detection, including a review of their limitations. [ABSTRACT FROM AUTHOR]

The COVID-19 pandemic has frightened people worldwide, and coronavirus has become the most commonly used phrase in recent years. Therefore, there is a need for a systematic literature review (SLR) related to Big Data applications in the COVID-19 pandemic crisis. The objective is to highlight recent technological advancements. Many studies emphasize the area of the COVID-19 pandemic crisis. Our study categorizes the many applications used to manage and control the pandemic. There is a very limited SLR prospective of COVID-19 with Big Data. Our SLR study picked five databases: Science direct, IEEE Xplore, Springer, ACM, and MDPI. Before the screening, following the recommendation, Preferred Reporting Items for Systematic Reviews and Meta Analyses (PRISMA) were reported for 893 studies from 2019, 2020 and until September 2021. After screening, 60 studies met the inclusion criteria through COVID-19 data statistics, and Big Data analysis was used as the search string. Our research's findings successfully dealt with COVID-19 healthcare with risk diagnosis, estimation or prevention, decision making, and drug Big Data applications problems. We believe that this review study will motivate the research community to perform expandable and transparent research against the pandemic crisis of COVID-19. [ABSTRACT FROM AUTHOR]

To use technology or engage with research or medical treatment typically requires user consent: agreeing to terms of use with technology or services, or providing informed consent for research participation, for clinical trials and medical intervention, or as one legal basis for processing personal data. Introducing AI technologies, where explainability and trustworthiness are focus items for both government guidelines and responsible technologists, imposes additional challenges. Understanding enough of the technology to be able to make an informed decision, or consent, is essential but involves an acceptance of uncertain outcomes. Further, the contribution of AI-enabled technologies not least during the COVID-19 pandemic raises ethical concerns about the governance associated with their development and deployment. Using three typical scenarios—contact tracing, big data analytics and research during public emergencies—this paper explores a trust-based alternative to consent. Unlike existing consent-based mechanisms, this approach sees consent as a typical behavioural response to perceived contextual characteristics. Decisions to engage derive from the assumption that all relevant stakeholders including research participants will negotiate on an ongoing basis. Accepting dynamic negotiation between the main stakeholders as proposed here introduces a specifically socio–psychological perspective into the debate about human responses to artificial intelligence. This trust-based consent process leads to a set of recommendations for the ethical use of advanced technologies as well as for the ethical review of applied research projects. [ABSTRACT FROM AUTHOR]

"Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)", the novel coronavirus, is responsible for the ongoing worldwide pandemic. "World Health Organization (WHO)" assigned an "International Classification of Diseases (ICD)" code—"COVID-19"-as the name of the new disease. Coronaviruses are generally transferred by people and many diverse species of animals, including birds and mammals such as cattle, camels, cats, and bats. Infrequently, the coronavirus can be transferred from animals to humans, and then propagate among people, such as with "Middle East Respiratory Syndrome (MERS-CoV)", "Severe Acute Respiratory Syndrome (SARS-CoV)", and now with this new virus, namely "SARS-CoV-2", or human coronavirus. Its rapid spreading has sent billions of people into lockdown as health services struggle to cope up. The COVID-19 outbreak comes along with an exponential growth of new infections, as well as a growing death count. A major goal to limit the further exponential spreading is to slow down the transmission rate, which is denoted by a "spread factor (f)", and we proposed an algorithm in this study for analyzing the same. This paper addresses the potential of data science to assess the risk factors correlated with COVID-19, after analyzing existing datasets available in "ourworldindata.org (Oxford University database)", and newly simulated datasets, following the analysis of different univariate "Long Short Term Memory (LSTM)" models for forecasting new cases and resulting deaths. The result shows that vanilla, stacked, and bidirectional LSTM models outperformed multilayer LSTM models. Besides, we discuss the findings related to the statistical analysis on simulated datasets. For correlation analysis, we included features, such as external temperature, rainfall, sunshine, population, infected cases, death, country, population, area, and population density of the past three months—January, February, and March in 2020. For univariate timeseries forecasting using LSTM, we used datasets from 1 January 2020, to 22 April 2020. [ABSTRACT FROM AUTHOR]